We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Skull-Implantable Ultrasound Device Enables Powerful Chemotherapy Drug to Reach Brain Tumors

By MedImaging International staff writers
Posted on 15 May 2023
Print article
Image: A novel, skull-implantable ultrasound device can open the blood-brain barrier to deliver chemotherapy (Photo courtesy of Northwestern Medicine)
Image: A novel, skull-implantable ultrasound device can open the blood-brain barrier to deliver chemotherapy (Photo courtesy of Northwestern Medicine)

A significant challenge in treating lethal brain cancer known as glioblastoma has been the inability of powerful chemotherapy to penetrate the blood-brain barrier to target the aggressive brain tumor. The blood-brain barrier is a microscopic structure that protects the brain from most circulating drugs, considerably limiting the range of medications that can be used to treat brain disorders. Consequently, most drugs that are effective for cancer in other parts of the body cannot be used to treat brain cancer because they are unable to cross the blood-brain barrier. Now, researchers have shared the results of the first human clinical trial in which a unique, skull-implantable ultrasound device was used to open the blood-brain barrier and allow chemotherapy, administered intravenously, to reach critical, large areas of the brain repeatedly. The procedure to open the blood-brain barrier, which lasts for about four minutes, is done with the patient awake and allows them to return home after a few hours. The results indicate that the treatment is safe and well-tolerated, with some patients undergoing up to six cycles of treatment.

This study by scientists at Northwestern Medicine (Evanston, IL, USA) was the first to effectively measure the impact of ultrasound-based blood-brain barrier opening on the levels of chemotherapy in the human brain. The results showed that opening the blood-brain barrier led to an estimated four- to six-fold increase in drug concentrations in the human brain. This increase was observed with two different potent chemotherapy drugs, paclitaxel and carboplatin, which are usually not used to treat these patients because they do not cross the blood-brain barrier under normal conditions.

In addition, the study was the first to describe how fast the blood-brain barrier closes after sonication. Previous human studies have indicated that the blood-brain barrier completely recovers 24 hours after brain sonication, and some animal studies have suggested that the blood-brain barrier remains open for roughly the first six hours. However, the researchers found that the opening of the blood-brain barrier using ultrasound and microbubbles is temporary, and the majority of the blood-brain barrier's integrity is restored within an hour after the procedure in humans. According to the researchers, these findings will help optimize the timing of drug delivery and ultrasound activation to maximize drug penetration into the human brain.

“This is potentially a huge advance for glioblastoma patients,” said lead investigator Dr. Adam Sonabend, an associate professor of neurological surgery at Northwestern University Feinberg School of Medicine and a Northwestern Medicine neurosurgeon. “While we have focused on brain cancer (for which there are approximately 30,000 gliomas in the U.S.), this opens the door to investigate novel drug-based treatments for millions of patients who suffer from various brain diseases.”

Related Links:
Northwestern Medicine 

Gold Supplier
Portable X-Ray System
FDR Xair
New
Image Sharing Platform
CareRad
New
CT Injector Syringe
MDT CT Injector Syringe
New
Silver Supplier
Field Calibration Instrument
DAPcheck Plus

Print article
FIME - Informa

Channels

Radiography

view channel
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)

Sustainable Solar Cell Material Could Revolutionize Medical Imaging

The use of X-rays for internal body imaging has dramatically changed non-invasive medical diagnostics. Yet, the high dose of X-rays required for these imaging techniques, due to the poor performance of... Read more

MRI

view channel
Image: Ezra Flash AI has received 510(k) FDA clearance, enabling roll out of the world’s first 30-minute full body MRI (Photo courtesy of Ezra)

World's First 30 Minute Full Body MRI Scan Offers Fast, Accurate and Affordable Cancer Diagnosis

A cutting-edge artificial intelligence (AI) solution enhances MR image quality, paving the way for a reduction in scan time and consequently, the cost of MRI procedures. This innovation now makes it feasible... Read more

Nuclear Medicine

view channel
Image: New imaging method offers potential for diagnosing, staging, and treating multiple types of cancer (Photo courtesy of SNMMI)

New Imaging Method Superior for Diagnosing Multiple Types of Cancer

Cancer-associated fibroblasts play a significant role in tumor development, migration, and progression. A subset of these fibroblasts expresses fibroblast activation protein (FAP), a protein prominently... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.